Tag: COVID-19

May 22, 2020 Off

Sinovac secures $15M for COVID-19 vaccine dvelopment

By BusinessWire

Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.